Alembic Pharmaceuticals Limited (APLLTD.NS) NSE

711.65

-13.85(-1.91%)

Updated at June 03 01:24PM

Currency In INR

Valuation

Market Cap130.36B
Enterprise Value142.64B
P/E Ratio20.73
PEG Ratio1.31
Price/Sales Ratio1.9
Price/Book Ratio2.46
Enterprise/Revenue2.07
Enterprise/EBITDA13.96

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.09
Operating Margin0.2

Management Effectiveness

Return On Assets0.08
Return On Equity0.13

Income Statement

Revenue73.45B
Revenue/Share373.59
Gross Profit33.1B
EBITDA11.18B
Net Income6.75B
Diluted EPS34.33

Balance Sheet

Total Cash2.03B
Total Cash/Share10.31
Total Debt14.3B
Total Debt/Equity0.25
Current Ratio1.76
Book Value Per Share288.34

Price History

52-Week Change-28.52
52-Week High1,107.9
52-Week Low635.8
Moving Average 50 Days736.82
Moving Average 200 Days824.94

Statistics

Average Volume125,555
Shares Outstanding196.56M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate11
Trailing Annual Dividend Yield1.55
Payout Ratio0.32
Last Split FactorN/A
Last Split DateN/A